An Evaluation Of Thermo Fisher Scientific Inc. (NYSE: TMO) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Thermo Fisher Scientific Increases Quarterly Dividend.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

TMO belongs to the Healthcare sector of the NYSE while operating in the Diagnostics & Research industry. The current market capitalization of Thermo Fisher Scientific Inc. is $215.33B. A total of 0.97 million shares were traded on the day, compared to an average of 1.73M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, TMO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 27 BUYs and 138 SELLs from insiders. Insiders purchased 130,124 shares during that period but sold 155,182.

In the most recent transaction, CASPER MARC N sold 5,547 shares of TMO for 550.62 per share on Feb 15. After the transaction, the Chairman & CEO now owns 43,608 company shares. In a previous transaction on Feb 12, Spar Debora L sold 164 shares at 546.97 per share. TMO shares that Director owns now total 1,207.

Among the insiders who sold shares, Boxer Michael A disposed of 14,566 shares on Feb 07 at a per-share price of $562.00. This resulted in the SVP and General Counsel holding 12,901 shares of TMO after the transaction. In another insider transaction, CASPER MARC N sold 10,000 shares at $555.63 per share on Feb 07. Company shares held by the Chairman & CEO now total 49,155.

Dividend

Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Thermo Fisher Scientific Inc. pays an annual dividend of $1.40, resulting in a dividend yield of 0.25%, and it has a price to earnings (P/E) ratio of 36.55. TMO’s most recent ex-dividend date was 3/14/2024 when it declared a $0.39 quarterly dividend that was paid in cash on 4/15/2024. Previously, the company paid the dividend on 1/16/2024 with an ex-dividend date of 12/14/2023. The TMO stock dividend was $0.35 per share in cash.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for TMO in the last 3 months, the mean price target is $596.43 with high estimates of $650.00 and low estimates of $520.00. In terms of 52-week highs and lows, TMO has a high of $593.17 and a low of $415.60.

As of this writing, TMO has an earnings estimate of $4.73 per share for the current quarter. EPS was calculated based on a consensus of 19 estimates, with a high estimate of $5 per share and a lower estimate of $4.64. The company reported an EPS of $5.69 in the last quarter, which was 1.40% higher than expectations of $5.61.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $120.87, while its Total Shareholder’s Equity was $40.98B.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.39.

Most Popular

Related Posts